Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-01 to 2025-04-22
Current total value of award: $57672.56
Description: 4567805861!KRYSTEXXA 8 MG/ML VIALML